Submission of Annual Report for the Financial Year 2025-26.

September 07, 2026 TAKE/BSE/2026-27 TAKE/NSE/2026-27 The Manager The Manager-Listing Dept. of Corporate Services-Listing Department National Stock Exchange of BSE Limited, India Limited P. J. Towers, Dalal Street, Exchange Plaza, Bandra - Kurla Complex, Mumbai - 400001 Bandra (East), Mumbai - 400051 Script Code: 532890 Scrip: TAKE Script Id: TAKE Ref: Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Submission of Annual Report for the Financial Year 2025-26. Dear Sir / Madam, Pursuant to Regulation 34(1) and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we hereby submit the Annual Report of TAKE Limited (formerly known as TAKE Solutions Limited) for the financial year ended March 31, 2026, duly approved by the Board of Directors of the Company. The Annual Report comprises, inter alia, the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2026, together with the Board’s Report, Management Discussion and Analysis Report, Corporate Governance Report, Auditors’ Reports and other applicable disclosures. The Annual Report is being submitted to the Stock Exchange for information and records and is also being made available on the website of the Company at www.takelimited.com. You are requested to take the above information on record. Thanking you. For TAKE Limited (formerly known as TAKE Solutions Limited) Sunil Patra Managing Director DIN: 11728362 TAKE LIMITED (formerly known as TAKE Solutions Limited) CIN: L72100TN2000PLC046338 Reg. Office Address: No. B3. No.9, B Block, Alsa Arcade, 3rd Floor, 2nd Avenue, Anna Nagar East, Chennai-600102, Tamil Nadu. Tel: 8108618322 E-mail: secretarial@takelimited.com Website: www.takelimited.com About TAKE TAKE, an AI-powered Health Intelligence application by TAKE Limited, represents the company’s vision of bringing advanced technology, data and health together to enable more personalised and measurable health optimisation. With TAKE Limited being publicly listed on both the NSE and BSE, the platform brings together personal health data, nutrition, lab insights and everyday health signals to help individuals better understand their health and make more informed decisions. Built around the principles of health optimisation, longevity and continuous improvement, Take aims to help people not just live longer, but live better for longer. Contents • Corporate Information • Notice of Annual General Meeting • General information for shareholders • Board’s Report and its Annexures • Management Discussion and Analysis • Corporate Governance Report • Certificate on Corporate Governance • Certificate of Non-Disqualification of Directors • MD/CFO Certificate • Standalone Financial Statements with Independent Auditors Report • Consolidated Financial Statements with Independent Auditors Report Corporate Information TAKE Limited (Formerly known as TAKE Solutions Limited) CIN: L72100TN2000PLC046338 Board of Directors Mr. Parmeshvar Dhangare Chairman and Non-executive Director Mr. Sunil Patra Managing Director and Chief Financial Officer Mr. Vilas Munis Non-executive Director Ms. Pushpa Joshi Independent Director Mr. Kanwar Nitin Singh Independent Director Mr. Peeyush Sethia Independent Director Key Managerial Personnels Ms. Vandana Gupta Company Secretary and Compliance Officer Committees of Board Audit Committee Nomination and Remuneration Committee Stakeholders Relationship Committee Risk Management Committee Statutory Auditors M/s. A. Raghavendra Rao & Associates, Chartered Accountants Secretarial Auditors M/s. Hemang Satra & Associates, Practicing Company Secretaries Internal Auditors M/s. Tejas Nadkarni & Associates, Chartered Accountants Registrar and Transfer Agent M/s. MUFG Intime India Private Limited Contact Registered Office Address: No. B3. No.9, B Block, Alsa Arcade, 3rd Floor, 2nd Avenue, Anna Nagar East, Chennai-600102, Tamil Nadu. Website: www.takelimited.com Email id: secretarial@takelimited.com Mobile: +91 8108618322 Banker HDFC Bank Limited. General Information for shareholders Sr. No. Particulars Details 1. CIN L72100TN2000PLC046338 2. Year of Incorporation 2000 3. BSE Script code 532890 4. BSE Script id TAKE 5. NSE Scrip TAKE 6. ISIN INE142I01023 7. Stock Exchange BSE Limited and National Stock Exchange of India Limited 8. Website www.takelimited.com 9. Contact no. +91 8108618322 10. Email id secretarial@takelimited.com 11. Correspondence Address No. B3. No.9, B Block, Alsa Arcade, 3rd Floor, 2nd Avenue, Anna Nagar East, Chennai- 600102, Tamil Nadu. 12. Date of AGM Tuesday, September 29, 2026 13. Time of AGM 12.00 P.M. 14. Venue of AGM Through VC/OAVM 15. Cut-off date for receiving AGM Friday, August 28, 2026 notice and Annual Report 16. Record date/cut-off date for E- Tuesday, September 22, 2026 voting 17. E-voting start date and time Saturday September 26, 2026 at 9.00 AM 18. E-voting end date and time Monday September 28, 2026 till 5.00 PM 19. EVSN 260904016 20. Name, address and contact details M/s. MUFG Intime India Private Limited. of Registrar and Transfer Agent Add: C 101, 247 Park, L.B.S. Marg, Vikhroli (West), (RTA) Mumbai-400 083, Maharashtra, India. Contact no: +91-8108116767 Email Id: investor.helpdesk@in.mpms.mufg.com Website: www.in.mpms.mufg.com TAKE Limited (Formerly known as TAKE Solutions Limited) Registered Office: No. B3. No.9, B Block, Alsa Arcade, 3rd Floor, 2nd Avenue, Anna Nagar East, Chennai-600102, Tamil Nadu CIN: L72100TN2000PLC046338 Tel: 8108618322; E-mail: secretarial@takelimited.com; Website: www.takelimited.com NOTICE OF THE TWENTY FIFTH ANNUAL GENERAL MEETING Notice is hereby given that the Twenty Fifth Annual General Meeting (“AGM”) of the members of TAKE Limited (Formerly known as TAKE Solutions Limited) (“Company”) is scheduled to be held on Tuesday, September 29, 2026 at 12.00 PM through video conferencing (“VC”) / Other Audio-visual means (“OAVM”) to transact the following businesses: Ordinary Businesses: 1. To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2026 and the Report of the Auditors thereon: To consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT the Audited Standalone Financial Statements of the Company for the financial year ended on March 31, 2026 and the Reports of the Board of Directors and the Report of the Auditors thereon, as circulated to the members, be and are hereby considered and adopted.” 2. To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2026 and the Report of the Auditors thereon: To consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT the Audited Consolidated Financial Statements of the Company for the financial year ended on March 31, 2026 and the Report of the Auditors thereon, as circulated to the members, be and are hereby considered and adopted.” 3. To appoint a director in place of Mr. Parmeshvar Dhangare (DIN: 11410125), who retires by rotation and being eligible, offer his candidature for re-appointment: To consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT Mr. Parmeshvar Dhangare (DIN: 11410125), who retires by rotation from the Board of Directors pursuant to the provisions of Section 152 of the Companies Act, 2013 be and is hereby re- appointed as a Director of the Company. RESOLVED FURTHER THAT any of the Directors for the time being are hereby severally authorized to sign and execute all such documents as may be required to give effect to this resolution and to do all such acts, deeds, matters and things as may considered expedient and necessary in this regard.” 4. To appoint M/s. A [Showing first 8,000 characters — download PDF for full document]